Stryker Corp
SYK355.310USD
+1.220+0.34%
Handelsschluss 12/15, 16:00（ET）Kurse um 15 Minuten verzögert
135.87BMarktkapitalisierung
46.12KGV TTM
mehr Informationen über Stryker Corp Unternehmen
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Stryker Corp Informationen
BörsenkürzelSYK
Name des UnternehmensStryker Corp
IPO-datumMar 17, 1980
CEOLobo (Kevin A)
Anzahl der mitarbeiter53000
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse1941 Stryker Way
StadtPORTAGE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl49002
Telefon12693852600
Websitehttps://www.stryker.com/
BörsenkürzelSYK
IPO-datumMar 17, 1980
CEOLobo (Kevin A)
Führungskräfte von Stryker Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
12.69K
-3.79%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
8.15K
-21.45%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
6.68K
-7.84%
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
6.38K
+9.63%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.78K
+10.74%
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
Independent Director
2.80K
+25.01%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
12.69K
-3.79%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
8.15K
-21.45%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medical
990.00M
16.44%
Trauma and Extremities
957.00M
15.89%
Endoscopy
899.00M
14.93%
Instruments
768.00M
12.75%
Knees
640.00M
10.63%
Andere
1.77B
29.36%
Nach RegionUSD
Name
Umsatz
Anteil
United States
4.55B
75.62%
International
1.47B
24.38%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medical
990.00M
16.44%
Trauma and Extremities
957.00M
15.89%
Endoscopy
899.00M
14.93%
Instruments
768.00M
12.75%
Knees
640.00M
10.63%
Andere
1.77B
29.36%
Aktionärsstatistik
Aktualisiert: Sat, Aug 16
Aktualisiert: Sat, Aug 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
8.79%
Brown (John W)
5.24%
Greenleaf Trust
4.35%
BlackRock Institutional Trust Company, N.A.
4.25%
State Street Investment Management (US)
3.91%
Andere
73.45%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
8.79%
Brown (John W)
5.24%
Greenleaf Trust
4.35%
BlackRock Institutional Trust Company, N.A.
4.25%
State Street Investment Management (US)
3.91%
Andere
73.45%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
45.41%
Investment Advisor/Hedge Fund
21.89%
Bank and Trust
6.61%
Individual Investor
5.36%
Research Firm
3.31%
Pension Fund
2.04%
Sovereign Wealth Fund
1.31%
Hedge Fund
1.15%
Family Office
0.13%
Andere
12.79%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
3494
311.59M
81.48%
-5.78M
2025Q2
3464
329.22M
86.11%
-1.59M
2025Q1
3477
331.34M
86.70%
+478.07K
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
2023Q3
2938
324.92M
85.54%
+14.80M
2023Q2
2898
325.04M
85.60%
+10.05M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
33.35M
8.72%
+437.93K
+1.33%
Jun 30, 2025
Brown (John W)
20.06M
5.25%
--
--
Feb 28, 2025
Greenleaf Trust
16.69M
4.37%
-427.58K
-2.50%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.08M
4.21%
-503.14K
-3.03%
Jun 30, 2025
State Street Investment Management (US)
14.96M
3.91%
+150.20K
+1.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
11.39M
2.98%
-237.74K
-2.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.39M
1.93%
+79.65K
+1.09%
Jun 30, 2025
JP Morgan Asset Management
7.37M
1.93%
-98.87K
-1.32%
Jun 30, 2025
AllianceBernstein L.P.
5.60M
1.46%
+4.22M
+307.57%
Jun 30, 2025
Capital Research Global Investors
6.77M
1.77%
-98.16K
-1.43%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Jensen Quality Growth ETF
6.01%
iShares U.S. Medical Devices ETF
4.17%
AdvisorShares Focused Equity ETF
3.62%
Gabelli Growth Innovators ETF
3%
Global X Aging Population ETF
2.85%
Hennessy Sustainable ETF
2.77%
Knowledge Leaders Developed World ETF
2.73%
Health Care Select Sector SPDR Fund
2.51%
Proshares Ultra Health Care
2.42%
iShares U.S. Healthcare ETF
2.4%
Mehr Anzeigen
Jensen Quality Growth ETF
Anteil6.01%
iShares U.S. Medical Devices ETF
Anteil4.17%
AdvisorShares Focused Equity ETF
Anteil3.62%
Gabelli Growth Innovators ETF
Anteil3%
Global X Aging Population ETF
Anteil2.85%
Hennessy Sustainable ETF
Anteil2.77%
Knowledge Leaders Developed World ETF
Anteil2.73%
Health Care Select Sector SPDR Fund
Anteil2.51%
Proshares Ultra Health Care
Anteil2.42%
iShares U.S. Healthcare ETF
Anteil2.4%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
5.22B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Aug 07, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Oct 31, 2025 going ex on Sep 30, 2025
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 08, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Jul 31, 2025 going ex on Jun 30, 2025
Jun 30, 2025
Jul 31, 2025
Jun 30, 2025
Feb 05, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Stryker Corp?
Die fünf größten Anteilseigner von Stryker Corp sind:
The Vanguard Group, Inc. hält 33.35M Aktien, was 8.72% der Gesamtaktien entspricht.
Brown (John W) hält 20.06M Aktien, was 5.25% der Gesamtaktien entspricht.
Greenleaf Trust hält 16.69M Aktien, was 4.37% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 16.08M Aktien, was 4.21% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 14.96M Aktien, was 3.91% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 33.35M Aktien, was 8.72% der Gesamtaktien entspricht.
Brown (John W) hält 20.06M Aktien, was 5.25% der Gesamtaktien entspricht.
Greenleaf Trust hält 16.69M Aktien, was 4.37% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 16.08M Aktien, was 4.21% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 14.96M Aktien, was 3.91% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Stryker Corp?
Die drei wichtigsten Anteilseigner-Typen von Stryker Corp sind:
The Vanguard Group, Inc.
Brown (John W)
Greenleaf Trust
The Vanguard Group, Inc.
Brown (John W)
Greenleaf Trust
Wie viele Institutionen halten Anteile an Stryker Corp (SYK)?
Mit Stand vom 2025Q3 halten 3494 Institutionen Anteile an Stryker Corp, mit einem Gesamtmarktwert von etwa 311.59M, was 81.48% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -4.63% gestiegen.
Was ist die größte Einnahmequelle von Stryker Corp?
Am FY2025Q2 erzielte das Geschäft mit Medical für Stryker Corp den höchsten Umsatz in Höhe von 990.00M, was 16.44% des Gesamtumsatzes entspricht.
